Sign In
Buy ALX
$281.63
-2.52 (-0.89%)
At Close: Jul 17, 2026
ALX Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
04:00pm, Thursday, 07'th Nov 2024
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing th
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, British Columbia--(Newsfile Corp. - November 7, 2024) - ALX Resources Corp. (TSXV: AL) (FSE
Alexander's (ALX) Tops Q3 FFO and Revenue Estimates
10:55am, Monday, 04'th Nov 2024
Alexander's (ALX) came out with quarterly funds from operations (FFO) of $2.84 per share, beating the Zacks Consensus Estimate of $2.57 per share. This compares to FFO of $3.63 per share a year ago.
Alexander's Announces Third Quarter Financial Results
09:16am, Monday, 04'th Nov 2024
PARAMUS, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- ALEXANDER'S, INC. (New York Stock Exchange: ALX) filed its Form 10-Q for the quarter ended September 30, 2024 today and reported:
Poster presentation will highlight new data from clinical trial evaluating evorpacept, a highly differentiated investigational CD47 blocker, in combination with zanidatamab, an investigational dual HE
Alexander's Declares Quarterly $4.50 Dividend on Common Shares
01:33pm, Wednesday, 30'th Oct 2024
PARAMUS, N.J., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that its Board of Directors has declared a regular quarterly dividend of $4.50 per share payable on Novem
Alexander's Announces Third Quarter Earnings Release Date and Vornado Realty Trust Quarterly Conference Call
01:45pm, Tuesday, 22'nd Oct 2024
PARAMUS, N.J., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that it will file its quarterly report on Form 10-Q for the quarter ended September 30, 2024 with the U.
Greenridge Exploration Enters into Binding Arrangement Agreement to Acquire ALX Resources Corp.
02:12pm, Friday, 11'th Oct 2024
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, British Columbia--(Newsfile Corp. - October 11, 2024) - Greenridge Exploration Inc. (CSE:
An October Surprise
09:00am, Sunday, 06'th Oct 2024
U.S. equity markets extended gains to a fourth-straight week despite a resurgence in benchmark interest rates after a critical slate of employment data showed surprisingly strong labor market trends.
Alexander's Completes $400 Million Refinancing of 731 Lexington Avenue Office Condominium
04:27pm, Monday, 30'th Sep 2024
PARAMUS, N.J., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that it has completed a $400 million refinancing of the office condominium portion of 731 Lexington Ave
Fed Rate Cuts Breathe New Life Into These High-Yield Stocks
11:01am, Sunday, 29'th Sep 2024
Real estate is great, except for the heavy time commitment, which makes it a non-starter for me. “Brett, can you come over and change my lightbulb?
Best Income Stocks to Buy for September 18th
09:50am, Wednesday, 18'th Sep 2024
ALX, JSAIY and NBTB made it to the Zacks Rank #1 (Strong Buy) income stocks list on September 18, 2024.
New Strong Buy Stocks for September 18th
07:36am, Wednesday, 18'th Sep 2024
SN, ALX, BPOP, ARCAY and JSAIY have been added to the Zacks Rank #1 (Strong Buy) List on September 18, 2024.
Best Income Stocks to Buy for September 13th
05:50am, Friday, 13'th Sep 2024
BANF, ALX and BPRN made it to the Zacks Rank #1 (Strong Buy) income stocks list on September 13, 2024.
ALX Oncology's Evorpacept Gains Momentum With FDA Fast Track Designations
10:36pm, Wednesday, 11'th Sep 2024
ALX Oncology's Evorpacept, a first-in-class CD47 inhibitor, shows promising results in cancer treatment with reduced side effects and a favorable safety profile. Evorpacept's combination with TRP demo
